" /> Cisplatin/Fluorouracil/Pembrolizumab/Trastuzumab Regimen - CISMeF





Preferred Label : Cisplatin/Fluorouracil/Pembrolizumab/Trastuzumab Regimen;

NCIt synonyms : Cisplatin/Fluorouracil/Pembrolizumab/Trastuzumab; Cisplatin-Fluorouracil-Pembrolizumab-Trastuzumab; Fluorouracil/Cisplatin/Pembrolizumab/Trastuzumab; Cisplatin/Fluorouracil/Keytruda/Herceptin Regimen;

NCIt related terms : Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-dttb; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-qyyp; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-herw; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-pkrb; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-dkst; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-zerc; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-anns;

NCIt definition : A regimen consisting of cisplatin, fluorouracil, pembrolizumab and trastuzumab that can be used in the treatment of esophageal and esophagogastric junction, and gastric cancers.;

NCI Metathesaurus CUI : CL1926251;

Codes from synonyms : 121882; 135074; 135069; 135071; 135073; 135068; 135070; 135072;

Details


You can consult :


Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.